{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:49:09Z","timestamp":1792882149923,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T00:00:00Z","timestamp":1513555200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2017,12,18]],"date-time":"2017-12-18T00:00:00Z","timestamp":1513555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA027825"],"award-info":[{"award-number":["DA027825"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Psychiatric Center Copenhagen"},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["U54MH084659"],"award-info":[{"award-number":["U54MH084659"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s00213-017-4797-0","type":"journal-article","created":{"date-parts":[[2017,12,17]],"date-time":"2017-12-17T21:45:41Z","timestamp":1513547141000},"page":"815-827","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Effects of muscarinic M1 and M4 acetylcholine receptor stimulation on extinction and reinstatement of cocaine seeking in male mice, independent of extinction learning"],"prefix":"10.1007","volume":"235","author":[{"given":"Kevin","family":"Stoll","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Lindsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7250-6006","authenticated-orcid":false,"given":"Morgane","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,18]]},"reference":[{"issue":"7","key":"4797_CR1","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nn1069","volume":"6","author":"DA Baker","year":"2003","unstructured":"Baker DA, McFarland K, Lake RW, Shen H, Tang XC, Toda S, Kalivas PW (2003) Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse. Nat Neurosci 6(7):743\u2013749. \n                    https:\/\/doi.org\/10.1038\/nn1069","journal-title":"Nat Neurosci"},{"issue":"9","key":"4797_CR2","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1523\/JNEUROSCI.12-09-03591.1992","volume":"12","author":"V Bernard","year":"1992","unstructured":"Bernard V, Normand E, Bloch B (1992) Phenotypical characterization of the rat striatal neurons expressing muscarinic receptor genes. J Neurosci 12(9):3591\u20133600","journal-title":"J Neurosci"},{"issue":"4","key":"4797_CR3","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1001\/archneur.1997.00550160091022","volume":"54","author":"NC Bodick","year":"1997","unstructured":"Bodick NC, Offen WW, Levey AI, Cutler NR, Gauthier SG, Satlin A, Shannon HE, Tollefson GD, Rasmussen K, Bymaster FP, Hurley DJ, Potter WZ, Paul SM (1997) Effects of xanomeline, a selective muscarinic receptor agonist, on cognitive function and behavioral symptoms in Alzheimer disease. Arch Neurol 54(4):465\u2013473. \n                    https:\/\/doi.org\/10.1001\/archneur.1997.00550160091022","journal-title":"Arch Neurol"},{"issue":"24","key":"4797_CR4","doi-asserted-by":"publisher","first-page":"6258","DOI":"10.1523\/JNEUROSCI.1678-08.2008","volume":"28","author":"P Bonsi","year":"2008","unstructured":"Bonsi P, Martella G, Cuomo D, Platania P, Sciamanna G, Bernardi G, Wess J, Pisani A (2008) Loss of muscarinic autoreceptor function impairs long-term depression but not long-term potentiation in the striatum. J Neurosci 28(24):6258\u20136263. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1678-08.2008","journal-title":"J Neurosci"},{"issue":"1","key":"4797_CR5","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1016\/j.bbr.2006.05.012","volume":"172","author":"F Botreau","year":"2006","unstructured":"Botreau F, Paolone G, Stewart J (2006) d-Cycloserine facilitates extinction of a cocaine-induced conditioned place preference. Behav Brain Res 172(1):173\u2013178. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2006.05.012","journal-title":"Behav Brain Res"},{"issue":"3","key":"4797_CR6","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1124\/jpet.108.140350","volume":"327","author":"AE Brady","year":"2008","unstructured":"Brady AE, Jones CK, Bridges TM, Kennedy JP, Thompson AD, Heiman JU, Breininger ML, Gentry PR, Yin H, Jadhav SB, Shirey JK, Conn PJ, Lindsley CW (2008) Centrally active allosteric potentiators of the M4 muscarinic acetylcholine receptor reverse amphetamine-induced hyperlocomotor activity in rats. J Pharmacol Exp Ther 327(3):941\u2013953. \n                    https:\/\/doi.org\/10.1124\/jpet.108.140350","journal-title":"J Pharmacol Exp Ther"},{"issue":"10","key":"4797_CR7","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1021\/cn500128b","volume":"5","author":"M Bubser","year":"2014","unstructured":"Bubser M, Bridges TM, Dencker D, Gould RW, Grannan M, Noetzel MJ, Lamsal A, Niswender CM, Daniels JS, Poslusney MS, Melancon BJ, Tarr JC, Byers FW, Wess J, Duggan ME, Dunlop J, Wood MW, Brandon NJ, Wood MR, Lindsley CW, Conn PJ, Jones CK (2014) Selective activation of M4 muscarinic acetylcholine receptors reverses MK-801-induced behavioral impairments and enhances associative learning in rodents. ACS Chem Neurosci 5(10):920\u2013942. \n                    https:\/\/doi.org\/10.1021\/cn500128b","journal-title":"ACS Chem Neurosci"},{"key":"4797_CR8","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/978-3-642-23274-9_7","volume":"208","author":"M Bubser","year":"2012","unstructured":"Bubser M, Byun N, Wood MR, Jones CK (2012) Muscarinic receptor pharmacology and circuitry for the modulation of cognition. Handb Exp Pharmacol 208:121\u2013166. \n                    https:\/\/doi.org\/10.1007\/978-3-642-23274-9_7","journal-title":"Handb Exp Pharmacol"},{"issue":"1","key":"4797_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s002130051134","volume":"147","author":"SB Caine","year":"1999","unstructured":"Caine SB, Negus SS, Mello NK (1999) Method for training operant responding and evaluating cocaine self-administration behavior in mutant mice. Psychopharmacology 147(1):22\u201324. \n                    https:\/\/doi.org\/10.1007\/s002130051134","journal-title":"Psychopharmacology"},{"issue":"5","key":"4797_CR10","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1037\/a0029135","volume":"20","author":"SB Caine","year":"2012","unstructured":"Caine SB, Thomsen M, Barrett AC, Collins GT, Grundt P, Newman AH, Butler P, Xu M (2012) Cocaine self-administration in dopamine D(3) receptor knockout mice. Exp Clin Psychopharmacol 20(5):352\u2013363. \n                    https:\/\/doi.org\/10.1037\/a0029135","journal-title":"Exp Clin Psychopharmacol"},{"issue":"48","key":"4797_CR11","doi-asserted-by":"publisher","first-page":"13140","DOI":"10.1523\/JNEUROSCI.2284-07.2007","volume":"27","author":"SB Caine","year":"2007","unstructured":"Caine SB, Thomsen M, Gabriel KI, Berkowitz JS, Gold LH, Koob GF, Tonegawa S, Zhang J, Xu M (2007) Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. J Neurosci 27(48):13140\u201313150. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.2284-07.2007","journal-title":"J Neurosci"},{"issue":"15","key":"4797_CR12","doi-asserted-by":"crossref","first-page":"RC89","DOI":"10.1523\/JNEUROSCI.20-15-j0006.2000","volume":"20","author":"JL Cornish","year":"2000","unstructured":"Cornish JL, Kalivas PW (2000) Glutamate transmission in the nucleus accumbens mediates relapse in cocaine addiction. J Neurosci 20(15):RC89","journal-title":"J Neurosci"},{"issue":"3","key":"4797_CR13","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1124\/pr.115.011668","volume":"68","author":"PW Czoty","year":"2016","unstructured":"Czoty PW, Stoops WW, Rush CR (2016) Evaluation of the \u201cpipeline\u201d for development of medications for cocaine use disorder: a review of translational preclinical, human laboratory, and clinical trial research. Pharmacol Rev 68(3):533\u2013562. \n                    https:\/\/doi.org\/10.1124\/pr.115.011668","journal-title":"Pharmacol Rev"},{"key":"4797_CR14","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.drugalcdep.2017.03.014","volume":"176","author":"CW Dall","year":"2017","unstructured":"Dall CW, Weikop P, Dencker D, Molander AC, W\u00f6rtwein G, Conn PJ, Fink-Jensen A, Thomsen M (2017) Muscarinic receptor M4 positive allosteric modulators attenuate central effects of cocaine. Drug Alcohol Depend 176:154\u2013161. \n                    https:\/\/doi.org\/10.1016\/j.drugalcdep.2017.03.014","journal-title":"Drug Alcohol Depend"},{"issue":"4352","key":"4797_CR15","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1126\/science.351807","volume":"201","author":"KL Davis","year":"1978","unstructured":"Davis KL, Mohs RC, Tinklenberg JR, Pfefferbaum A, Hollister LE, Kopell BS (1978) Physostigmine: improvement of long-term memory processes in normal humans. Science 201(4352):272\u2013274. \n                    https:\/\/doi.org\/10.1126\/science.351807","journal-title":"Science"},{"issue":"2","key":"4797_CR16","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1007\/s00213-012-2751-8","volume":"224","author":"D Dencker","year":"2012","unstructured":"Dencker D, Weikop P, Sorensen G, Woldbye DP, Wortwein G, Wess J, Fink-Jensen A (2012) An allosteric enhancer of M(4) muscarinic acetylcholine receptor function inhibits behavioral and neurochemical effects of cocaine. Psychopharmacology 224(2):277\u2013287. \n                    https:\/\/doi.org\/10.1007\/s00213-012-2751-8","journal-title":"Psychopharmacology"},{"issue":"2","key":"4797_CR17","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.neuron.2010.06.017","volume":"67","author":"JB Ding","year":"2010","unstructured":"Ding JB, Guzman JN, Peterson JD, Goldberg JA, Surmeier DJ (2010) Thalamic gating of corticostriatal signaling by cholinergic interneurons. Neuron 67(2):294\u2013307. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2010.06.017","journal-title":"Neuron"},{"issue":"6","key":"4797_CR18","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1016\/j.neuron.2016.08.017","volume":"91","author":"DJ Foster","year":"2016","unstructured":"Foster DJ, Wilson JM, Remke DH, Mahmood MS, Uddin MJ, Wess J, Patel S, Marnett LJ, Niswender CM, Jones CK, Xiang Z, Lindsley CW, Rook JM, Conn PJ (2016) Antipsychotic-like effects of M4 positive allosteric modulators are mediated by CB2 receptor-dependent inhibition of dopamine release. Neuron 91(6):1244\u20131252. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2016.08.017","journal-title":"Neuron"},{"issue":"1-2","key":"4797_CR19","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1159\/000357682","volume":"93","author":"CR Galloway","year":"2014","unstructured":"Galloway CR, Lebois EP, Shagarabi SL, Hernandez NA, Manns JR (2014) Effects of selective activation of M1 and M4 muscarinic receptors on object recognition memory performance in rats. Pharmacology 93(1-2):57\u201364. \n                    https:\/\/doi.org\/10.1159\/000357682","journal-title":"Pharmacology"},{"issue":"26","key":"4797_CR20","doi-asserted-by":"publisher","first-page":"15312","DOI":"10.1073\/pnas.261583798","volume":"98","author":"DJ Gerber","year":"2001","unstructured":"Gerber DJ, Sotnikova TD, Gainetdinov RR, Huang SY, Caron MG, Tonegawa S (2001) Hyperactivity, elevated dopaminergic transmission, and response to amphetamine in M1 muscarinic acetylcholine receptor-deficient mice. Proc Natl Acad Sci U S A 98(26):15312\u201315317. \n                    https:\/\/doi.org\/10.1073\/pnas.261583798","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4797_CR21","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/978-3-642-23274-9_10","volume":"208","author":"JA Goldberg","year":"2012","unstructured":"Goldberg JA, Ding JB, Surmeier DJ (2012) Muscarinic modulation of striatal function and circuitry. Handb Exp Pharmacol 208:223\u2013241. \n                    https:\/\/doi.org\/10.1007\/978-3-642-23274-9_10","journal-title":"Handb Exp Pharmacol"},{"key":"4797_CR22","doi-asserted-by":"publisher","unstructured":"Gould RW, Grannan MD, Gunter BW, Ball J, Bubser M, Bridges TM, Wess J, Wood MW, Brandon NJ, Duggan ME, Niswender CM, Lindsley CW, Conn PJ, Jones CK (2017) Cognitive enhancement and antipsychotic-like activity following repeated dosing with the selective M4 PAM VU0467154. Neuropharmacology. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2017.07.013","DOI":"10.1016\/j.neuropharm.2017.07.013"},{"issue":"3","key":"4797_CR23","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1124\/jpet.104.067264","volume":"310","author":"Y Grabovsky","year":"2004","unstructured":"Grabovsky Y, Tallarida RJ (2004) Isobolographic analysis for combinations of a full and partial agonist: curved isoboles. J Pharmacol Exp Ther 310(3):981\u2013986. \n                    https:\/\/doi.org\/10.1124\/jpet.104.067264","journal-title":"J Pharmacol Exp Ther"},{"key":"4797_CR24","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.phrs.2015.04.003","volume":"97","author":"K Grasing","year":"2015","unstructured":"Grasing K, Yang Y, He S (2015) Enduring effects of tacrine on cocaine-reinforced behavior: analysis by conditioned-place preference, temporal separation from drug reward, and reinstatement. Pharmacological Research: The Official Journal of the Italian Pharmacological Society 97:40\u201347. \n                    https:\/\/doi.org\/10.1016\/j.phrs.2015.04.003","journal-title":"Pharmacological Research: The Official Journal of the Italian Pharmacological Society"},{"issue":"5 Pt 2","key":"4797_CR25","doi-asserted-by":"crossref","first-page":"3351","DOI":"10.1523\/JNEUROSCI.14-05-03351.1994","volume":"14","author":"SM Hersch","year":"1994","unstructured":"Hersch SM, Gutekunst CA, Rees HD, Heilman CJ, Levey AI (1994) Distribution of m1-m4 muscarinic receptor proteins in the rat striatum: light and electron microscopic immunocytochemistry using subtype-specific antibodies. J Neurosci 14(5 Pt 2):3351\u20133363","journal-title":"J Neurosci"},{"issue":"11-12","key":"4797_CR26","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/0024-3205(95)00030-A","volume":"56","author":"SM Hersch","year":"1995","unstructured":"Hersch SM, Levey AI (1995) Diverse pre- and post-synaptic expression of m1-m4 muscarinic receptor proteins in neurons and afferents in the rat neostriatum. Life Sci 56(11-12):931\u2013938. \n                    https:\/\/doi.org\/10.1016\/0024-3205(95)00030-A","journal-title":"Life Sci"},{"issue":"9","key":"4797_CR27","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/nn.2368","volume":"12","author":"MJ Higley","year":"2009","unstructured":"Higley MJ, Soler-Llavina GJ, Sabatini BL (2009) Cholinergic modulation of multivesicular release regulates striatal synaptic potency and integration. Nat Neurosci 12(9):1121\u20131128. \n                    https:\/\/doi.org\/10.1038\/nn.2368","journal-title":"Nat Neurosci"},{"issue":"4","key":"4797_CR28","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1002\/(SICI)1098-2396(199712)27:4<357::AID-SYN9>3.0.CO;2-B","volume":"27","author":"E Ince","year":"1997","unstructured":"Ince E, Ciliax BJ, Levey AI (1997) Differential expression of D1 and D2 dopamine and m4 muscarinic acetylcholine receptor proteins in identified striatonigral neurons. Synapse 27(4):357\u2013366. \n                    https:\/\/doi.org\/10.1002\/(SICI)1098-2396(199712)27:4<357::AID-SYN9>3.0.CO;2-B","journal-title":"Synapse"},{"issue":"6","key":"4797_CR29","doi-asserted-by":"publisher","first-page":"2396","DOI":"10.1523\/JNEUROSCI.3843-09.2010","volume":"30","author":"J Jeon","year":"2010","unstructured":"Jeon J, Dencker D, Wortwein G, Woldbye DP, Cui Y, Davis AA, Levey AI, Schutz G, Sager TN, Mork A, Li C, Deng CX, Fink-Jensen A, Wess J (2010) A subpopulation of neuronal M4 muscarinic acetylcholine receptors plays a critical role in modulating dopamine-dependent behaviors. J Neurosci 30(6):2396\u20132405. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3843-09.2010","journal-title":"J Neurosci"},{"issue":"8","key":"4797_CR30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrn2515","volume":"10","author":"PW Kalivas","year":"2009","unstructured":"Kalivas PW (2009) The glutamate homeostasis hypothesis of addiction. Nat Rev Neurosci 10(8):561\u2013572. \n                    https:\/\/doi.org\/10.1038\/nrn2515","journal-title":"Nat Rev Neurosci"},{"issue":"8","key":"4797_CR31","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1176\/appi.ajp.162.8.1403","volume":"162","author":"PW Kalivas","year":"2005","unstructured":"Kalivas PW, Volkow ND (2005) The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 162(8):1403\u20131413. \n                    https:\/\/doi.org\/10.1176\/appi.ajp.162.8.1403","journal-title":"Am J Psychiatry"},{"issue":"3","key":"4797_CR32","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1016\/j.bmc.2007.10.058","volume":"16","author":"BE Kane","year":"2008","unstructured":"Kane BE, Grant MK, El-Fakahany EE, Ferguson DM (2008) Synthesis and evaluation of xanomeline analogs\u2014probing the wash-resistant phenomenon at the M1 muscarinic acetylcholine receptor. Bioorg Med Chem 16(3):1376\u20131392. \n                    https:\/\/doi.org\/10.1016\/j.bmc.2007.10.058","journal-title":"Bioorg Med Chem"},{"issue":"3","key":"4797_CR33","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1016\/j.pbb.2010.08.004","volume":"97","author":"GB Kaplan","year":"2011","unstructured":"Kaplan GB, Heinrichs SC, Carey RJ (2011) Treatment of addiction and anxiety using extinction approaches: neural mechanisms and their treatment implications. Pharmacol Biochem Behav 97(3):619\u2013625. \n                    https:\/\/doi.org\/10.1016\/j.pbb.2010.08.004","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"4797_CR34","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.biopsych.2009.07.018","volume":"67","author":"LA Knackstedt","year":"2010","unstructured":"Knackstedt LA, Melendez RI, Kalivas PW (2010b) Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol Psychiatry 67(1):81\u201384. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2009.07.018","journal-title":"Biol Psychiatry"},{"issue":"23","key":"4797_CR35","doi-asserted-by":"publisher","first-page":"7984","DOI":"10.1523\/JNEUROSCI.1244-10.2010","volume":"30","author":"LA Knackstedt","year":"2010","unstructured":"Knackstedt LA, Moussawi K, Lalumiere R, Schwendt M, Klugmann M, Kalivas PW (2010a) Extinction training after cocaine self-administration induces glutamatergic plasticity to inhibit cocaine seeking. J Neurosci 30(23):7984\u20137992. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1244-10.2010","journal-title":"J Neurosci"},{"issue":"2","key":"4797_CR36","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.euroneuro.2015.12.022","volume":"26","author":"AL LaCrosse","year":"2016","unstructured":"LaCrosse AL, Hill K, Knackstedt LA (2016) Ceftriaxone attenuates cocaine relapse after abstinence through modulation of nucleus accumbens AMPA subunit expression. Eur Neuropsychopharmacol 26(2):186\u2013194. \n                    https:\/\/doi.org\/10.1016\/j.euroneuro.2015.12.022","journal-title":"Eur Neuropsychopharmacol"},{"issue":"2","key":"4797_CR37","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1021\/cn900003h","volume":"1","author":"EP Lebois","year":"2010","unstructured":"Lebois EP, Bridges TM, Lewis LM, Dawson ES, Kane AS, Xiang Z, Jadhav SB, Yin H, Kennedy JP, Meiler J, Niswender CM, Jones CK, Conn PJ, Weaver CD, Lindsley CW (2010) Discovery and characterization of novel subtype-selective allosteric agonists for the investigation of M(1) receptor function in the central nervous system. ACS Chem Neurosci 1(2):104\u2013121. \n                    https:\/\/doi.org\/10.1021\/cn900003h","journal-title":"ACS Chem Neurosci"},{"issue":"2","key":"4797_CR38","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1037\/0735-7044.117.2.341","volume":"117","author":"L Ledgerwood","year":"2003","unstructured":"Ledgerwood L, Richardson R, Cranney J (2003) Effects of d-cycloserine on extinction of conditioned freezing. Behav Neurosci 117(2):341\u2013349. \n                    https:\/\/doi.org\/10.1037\/0735-7044.117.2.341","journal-title":"Behav Neurosci"},{"issue":"10","key":"4797_CR39","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1523\/JNEUROSCI.11-10-03218.1991","volume":"11","author":"AI Levey","year":"1991","unstructured":"Levey AI, Kitt CA, Simonds WF, Price DL, Brann MR (1991) Identification and localization of muscarinic acetylcholine receptor proteins in brain with subtype-specific antibodies. J Neurosci 11(10):3218\u20133226","journal-title":"J Neurosci"},{"issue":"2-3","key":"4797_CR40","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/BF02244907","volume":"112","author":"A Markou","year":"1993","unstructured":"Markou A, Weiss F, Gold LH, Caine SB, Schulteis G, Koob GF (1993) Animal models of drug craving. Psychopharmacology 112(2-3):163\u2013182. \n                    https:\/\/doi.org\/10.1007\/BF02244907","journal-title":"Psychopharmacology"},{"issue":"5451","key":"4797_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1126\/science.287.5451.248","volume":"287","author":"JL McGaugh","year":"2000","unstructured":"McGaugh JL (2000) Memory\u2014a century of consolidation. Science 287(5451):248\u2013251. \n                    https:\/\/doi.org\/10.1126\/science.287.5451.248","journal-title":"Science"},{"issue":"2","key":"4797_CR42","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1016\/j.bbr.2010.10.037","volume":"217","author":"EZ Millan","year":"2011","unstructured":"Millan EZ, Marchant NJ, McNally GP (2011) Extinction of drug seeking. Behav Brain Res 217(2):454\u2013462. \n                    https:\/\/doi.org\/10.1016\/j.bbr.2010.10.037","journal-title":"Behav Brain Res"},{"issue":"2","key":"4797_CR43","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1527-3458.2003.tb00247.x","volume":"9","author":"NR Mirza","year":"2003","unstructured":"Mirza NR, Peters D, Sparks RG (2003) Xanomeline and the antipsychotic potential of muscarinic receptor subtype selective agonists. CNS Drug Rev 9(2):159\u2013186","journal-title":"CNS Drug Rev"},{"issue":"14","key":"4797_CR44","doi-asserted-by":"crossref","first-page":"5239","DOI":"10.1523\/JNEUROSCI.21-14-05239.2001","volume":"21","author":"T Miyakawa","year":"2001","unstructured":"Miyakawa T, Yamada M, Duttaroy A, Wess J (2001) Hyperactivity and intact hippocampus-dependent learning in mice lacking the M1 muscarinic acetylcholine receptor. J Neurosci 21(14):5239\u20135250","journal-title":"J Neurosci"},{"issue":"11","key":"4797_CR45","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1016\/j.biopsych.2012.02.030","volume":"71","author":"KM Myers","year":"2012","unstructured":"Myers KM, Carlezon WA Jr (2012) d-cycloserine effects on extinction of conditioned responses to drug-related cues. Biol Psychiatry 71(11):947\u2013955. \n                    https:\/\/doi.org\/10.1016\/j.biopsych.2012.02.030","journal-title":"Biol Psychiatry"},{"issue":"3","key":"4797_CR46","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1523\/JNEUROSCI.4644-06.2007","volume":"27","author":"M Narushima","year":"2007","unstructured":"Narushima M, Uchigashima M, Fukaya M, Matsui M, Manabe T, Hashimoto K, Watanabe M, Kano M (2007) Tonic enhancement of endocannabinoid-mediated retrograde suppression of inhibition by cholinergic interneuron activity in the striatum. J Neurosci 27(3):496\u2013506. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.4644-06.2007","journal-title":"J Neurosci"},{"issue":"2","key":"4797_CR47","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.pbb.2011.01.018","volume":"99","author":"BA Nic Dhonnchadha","year":"2011","unstructured":"Nic Dhonnchadha BA, Kantak KM (2011) Cognitive enhancers for facilitating drug cue extinction: insights from animal models. Pharmacol Biochem Behav 99(2):229\u2013244. \n                    https:\/\/doi.org\/10.1016\/j.pbb.2011.01.018","journal-title":"Pharmacol Biochem Behav"},{"key":"4797_CR48","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.nbd.2013.09.013","volume":"61","author":"HH Nickols","year":"2014","unstructured":"Nickols HH, Conn PJ (2014) Development of allosteric modulators of GPCRs for treatment of CNS disorders. Neurobiol Dis 61:55\u201371. \n                    https:\/\/doi.org\/10.1016\/j.nbd.2013.09.013","journal-title":"Neurobiol Dis"},{"key":"4797_CR49","doi-asserted-by":"publisher","first-page":"3778","DOI":"10.1038\/ncomms4778","volume":"5","author":"K Okada","year":"2014","unstructured":"Okada K, Nishizawa K, Fukabori R, Kai N, Shiota A, Ueda M, Tsutsui Y, Sakata S, Matsushita N, Kobayashi K (2014) Enhanced flexibility of place discrimination learning by targeting striatal cholinergic interneurons. Nat Commun 5:3778. \n                    https:\/\/doi.org\/10.1038\/ncomms4778","journal-title":"Nat Commun"},{"issue":"3","key":"4797_CR50","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.conb.2011.04.004","volume":"21","author":"IA Oldenburg","year":"2011","unstructured":"Oldenburg IA, Ding JB (2011) Cholinergic modulation of synaptic integration and dendritic excitability in the striatum. Curr Opin Neurobiol 21(3):425\u2013432. \n                    https:\/\/doi.org\/10.1016\/j.conb.2011.04.004","journal-title":"Curr Opin Neurobiol"},{"issue":"2","key":"4797_CR51","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1523\/JNEUROSCI.3709-06.2007","volume":"27","author":"P Pakhotin","year":"2007","unstructured":"Pakhotin P, Bracci E (2007) Cholinergic interneurons control the excitatory input to the striatum. J Neurosci 27(2):391\u2013400. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.3709-06.2007","journal-title":"J Neurosci"},{"issue":"4","key":"4797_CR52","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1021\/cn500003z","volume":"5","author":"T Pancani","year":"2014","unstructured":"Pancani T, Bolarinwa C, Smith Y, Lindsley CW, Conn PJ, Xiang Z (2014) M4 mAChR-mediated modulation of glutamatergic transmission at corticostriatal synapses. ACS Chem Neurosci 5(4):318\u2013324. \n                    https:\/\/doi.org\/10.1021\/cn500003z","journal-title":"ACS Chem Neurosci"},{"issue":"45","key":"4797_CR53","doi-asserted-by":"publisher","first-page":"14078","DOI":"10.1073\/pnas.1512812112","volume":"112","author":"T Pancani","year":"2015","unstructured":"Pancani T, Foster DJ, Moehle MS, Bichell TJ, Bradley E, Bridges TM, Klar R, Poslusney M, Rook JM, Daniels JS, Niswender CM, Jones CK, Wood MR, Bowman AB, Lindsley CW, Xiang Z, Conn PJ (2015) Allosteric activation of M4 muscarinic receptors improve behavioral and physiological alterations in early symptomatic YAC128 mice. Proc Natl Acad Sci U S A 112(45):14078\u201314083. \n                    https:\/\/doi.org\/10.1073\/pnas.1512812112","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"23","key":"4797_CR54","doi-asserted-by":"publisher","first-page":"6046","DOI":"10.1523\/JNEUROSCI.1045-08.2008","volume":"28","author":"J Peters","year":"2008","unstructured":"Peters J, LaLumiere RT, Kalivas PW (2008) Infralimbic prefrontal cortex is responsible for inhibiting cocaine seeking in extinguished rats. J Neurosci 28(23):6046\u20136053. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1045-08.2008","journal-title":"J Neurosci"},{"issue":"10","key":"4797_CR55","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.tins.2007.07.008","volume":"30","author":"A Pisani","year":"2007","unstructured":"Pisani A, Bernardi G, Ding J, Surmeier DJ (2007) Re-emergence of striatal cholinergic interneurons in movement disorders. Trends Neurosci 30(10):545\u2013553. \n                    https:\/\/doi.org\/10.1016\/j.tins.2007.07.008","journal-title":"Trends Neurosci"},{"issue":"3","key":"4797_CR56","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1074-7427(03)00086-8","volume":"80","author":"AE Power","year":"2003","unstructured":"Power AE, Vazdarjanova A, McGaugh JL (2003) Muscarinic cholinergic influences in memory consolidation. Neurobiol Learn Mem 80(3):178\u2013193. \n                    https:\/\/doi.org\/10.1016\/S1074-7427(03)00086-8","journal-title":"Neurobiol Learn Mem"},{"issue":"4","key":"4797_CR57","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1007\/s00213-011-2592-x","volume":"226","author":"KL Price","year":"2013","unstructured":"Price KL, Baker NL, McRae-Clark AL, Saladin ME, Desantis SM, Santa Ana EJ, Brady KT (2013) A randomized, placebo-controlled laboratory study of the effects of d-cycloserine on craving in cocaine-dependent individuals. Psychopharmacology 226(4):739\u2013746. \n                    https:\/\/doi.org\/10.1007\/s00213-011-2592-x","journal-title":"Psychopharmacology"},{"issue":"2","key":"4797_CR58","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/npp.2013.223","volume":"39","author":"KJ Reissner","year":"2014","unstructured":"Reissner KJ, Brown RM, Spencer S, Tran PK, Thomas CA, Kalivas PW (2014) Chronic administration of the methylxanthine propentofylline impairs reinstatement to cocaine by a GLT-1-dependent mechanism. Neuropsychopharmacology 39(2):499\u2013506. \n                    https:\/\/doi.org\/10.1038\/npp.2013.223","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"4797_CR59","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1111\/ajad.12191","volume":"24","author":"EJ Santa Ana","year":"2015","unstructured":"Santa Ana EJ, Prisciandaro JJ, Saladin ME, McRae-Clark AL, Shaftman SR, Nietert PJ, Brady KT (2015) d-cycloserine combined with cue exposure therapy fails to attenuate subjective and physiological craving in cocaine dependence. Am J Addict 24(3):217\u2013224. \n                    https:\/\/doi.org\/10.1111\/ajad.12191","journal-title":"Am J Addict"},{"issue":"1-3","key":"4797_CR60","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.ejphar.2005.09.068","volume":"526","author":"HD Schmidt","year":"2005","unstructured":"Schmidt HD, Anderson SM, Famous KR, Kumaresan V, Pierce RC (2005) Anatomy and pharmacology of cocaine priming-induced reinstatement of drug seeking. Eur J Pharmacol 526(1-3):65\u201376. \n                    https:\/\/doi.org\/10.1016\/j.ejphar.2005.09.068","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"4797_CR61","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00213-011-2225-4","volume":"216","author":"LS Schmidt","year":"2011","unstructured":"Schmidt LS, Thomsen M, Weikop P, Dencker D, Wess J, Woldbye DP, Wortwein G, Fink-Jensen A (2011) Increased cocaine self-administration in M4 muscarinic acetylcholine receptor knockout mice. Psychopharmacology 216(3):367\u2013378. \n                    https:\/\/doi.org\/10.1007\/s00213-011-2225-4","journal-title":"Psychopharmacology"},{"issue":"5","key":"4797_CR62","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1101\/lm.78504","volume":"11","author":"JP Schroeder","year":"2004","unstructured":"Schroeder JP, Packard MG (2004) Facilitation of memory for extinction of drug-induced conditioned reward: role of amygdala and acetylcholine. Learn Mem 11(5):641\u2013647. \n                    https:\/\/doi.org\/10.1101\/lm.78504","journal-title":"Learn Mem"},{"issue":"8","key":"4797_CR63","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1176\/appi.ajp.2008.06091591","volume":"165","author":"A Shekhar","year":"2008","unstructured":"Shekhar A, Potter WZ, Lightfoot J, Lienemann J, Dube S, Mallinckrodt C, Bymaster FP, McKinzie DL, Felder CC (2008) Selective muscarinic receptor agonist xanomeline as a novel treatment approach for schizophrenia. Am J Psychiatry 165(8):1033\u20131039. \n                    https:\/\/doi.org\/10.1176\/appi.ajp.2008.06091591","journal-title":"Am J Psychiatry"},{"issue":"32","key":"4797_CR64","doi-asserted-by":"publisher","first-page":"7449","DOI":"10.1523\/JNEUROSCI.1381-05.2005","volume":"25","author":"W Shen","year":"2005","unstructured":"Shen W, Hamilton SE, Nathanson NM, Surmeier DJ (2005) Cholinergic suppression of KCNQ channel currents enhances excitability of striatal medium spiny neurons. J Neurosci 25(32):7449\u20137458. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.1381-05.2005","journal-title":"J Neurosci"},{"issue":"4","key":"4797_CR65","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.neuron.2015.10.039","volume":"88","author":"W Shen","year":"2015","unstructured":"Shen W, Plotkin JL, Francardo V, Ko WK, Xie Z, Li Q, Fieblinger T, Wess J, Neubig RR, Lindsley CW, Conn PJ, Greengard P, Bezard E, Cenci MA, Surmeier DJ (2015) M4 muscarinic receptor signaling ameliorates striatal plasticity deficits in models of L-DOPA-induced dyskinesia. Neuron 88(4):762\u2013773. \n                    https:\/\/doi.org\/10.1016\/j.neuron.2015.10.039","journal-title":"Neuron"},{"issue":"11","key":"4797_CR66","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/nn1972","volume":"10","author":"W Shen","year":"2007","unstructured":"Shen W, Tian X, Day M, Ulrich S, Tkatch T, Nathanson NM, Surmeier DJ (2007) Cholinergic modulation of Kir2 channels selectively elevates dendritic excitability in striatopallidal neurons. Nat Neurosci 10(11):1458\u20131466. \n                    https:\/\/doi.org\/10.1038\/nn1972","journal-title":"Nat Neurosci"},{"key":"4797_CR67","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.pharmthera.2014.12.004","volume":"149","author":"N Singewald","year":"2015","unstructured":"Singewald N, Schmuckermair C, Whittle N, Holmes A, Ressler KJ (2015) Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders. Pharmacol Ther 149:150\u2013190. \n                    https:\/\/doi.org\/10.1016\/j.pharmthera.2014.12.004","journal-title":"Pharmacol Ther"},{"issue":"4352","key":"4797_CR68","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1126\/science.351808","volume":"201","author":"N Sitaram","year":"1978","unstructured":"Sitaram N, Weingartner H, Gillin JC (1978) Human serial learning: enhancement with arecholine and choline impairment with scopolamine. Science 201(4352):274\u2013276. \n                    https:\/\/doi.org\/10.1126\/science.351808","journal-title":"Science"},{"issue":"10","key":"4797_CR69","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.tips.2015.07.002","volume":"36","author":"P Skolnick","year":"2015","unstructured":"Skolnick P (2015) Biologic approaches to treat substance-use disorders. Trends Pharmacol Sci 36(10):628\u2013635. \n                    https:\/\/doi.org\/10.1016\/j.tips.2015.07.002","journal-title":"Trends Pharmacol Sci"},{"key":"4797_CR70","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.neuropharm.2012.06.021","volume":"64","author":"M Sofuoglu","year":"2013","unstructured":"Sofuoglu M, DeVito EE, Waters AJ, Carroll KM (2013) Cognitive enhancement as a treatment for drug addictions. Neuropharmacology 64:452\u2013463. \n                    https:\/\/doi.org\/10.1016\/j.neuropharm.2012.06.021","journal-title":"Neuropharmacology"},{"issue":"1","key":"4797_CR71","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1080\/15504263.2016.1146383","volume":"12","author":"M Sofuoglu","year":"2016","unstructured":"Sofuoglu M, DeVito EE, Waters AJ, Carroll KM (2016) Cognitive function as a transdiagnostic treatment target in stimulant use disorders. J Dual Diagn 12(1):90\u2013106. \n                    https:\/\/doi.org\/10.1080\/15504263.2016.1146383","journal-title":"J Dual Diagn"},{"issue":"11","key":"4797_CR72","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1177\/0269881116655248","volume":"30","author":"S Spencer","year":"2016","unstructured":"Spencer S, Scofield M, Kalivas PW (2016) The good and bad news about glutamate in drug addiction. J Psychopharmacol 30(11):1095\u20131098. \n                    https:\/\/doi.org\/10.1177\/0269881116655248","journal-title":"J Psychopharmacol"},{"issue":"1","key":"4797_CR73","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.1369-1600.2012.00479.x","volume":"18","author":"MT Stefanik","year":"2013","unstructured":"Stefanik MT, Moussawi K, Kupchik YM, Smith KC, Miller RL, Huff ML, Deisseroth K, Kalivas PW, LaLumiere RT (2013) Optogenetic inhibition of cocaine seeking in rats. Addict Biol 18(1):50\u201353. \n                    https:\/\/doi.org\/10.1111\/j.1369-1600.2012.00479.x","journal-title":"Addict Biol"},{"issue":"7594","key":"4797_CR74","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1038\/nature17188","volume":"531","author":"DM Thal","year":"2016","unstructured":"Thal DM, Sun B, Feng D, Nawaratne V, Leach K, Felder CC, Bures MG, Evans DA, Weis WI, Bachhawat P, Kobilka TS, Sexton PM, Kobilka BK, Christopoulos A (2016) Crystal structures of the M1 and M4 muscarinic acetylcholine receptors. Nature 531(7594):335\u2013340. \n                    https:\/\/doi.org\/10.1038\/nature17188","journal-title":"Nature"},{"issue":"4","key":"4797_CR75","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/FBP.0000000000000043","volume":"25","author":"M Thomsen","year":"2014","unstructured":"Thomsen M (2014) Locomotor activating effects of cocaine and scopolamine combinations in rats: isobolographic analysis. Behav Pharmacol 25(4):259\u2013266. \n                    https:\/\/doi.org\/10.1097\/FBP.0000000000000043","journal-title":"Behav Pharmacol"},{"issue":"Unit 9","key":"4797_CR76","first-page":"20","volume":"Chapter 9","author":"M Thomsen","year":"2005","unstructured":"Thomsen M, Caine SB (2005) Chronic intravenous drug self-administration in rats and mice. Curr Protoc Neurosci Chapter 9(Unit 9):20","journal-title":"Curr Protoc Neurosci"},{"issue":"2","key":"4797_CR77","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1007\/s00213-005-0207-0","volume":"184","author":"M Thomsen","year":"2006","unstructured":"Thomsen M, Caine SB (2006) Cocaine self-administration under fixed and progressive ratio schedules of reinforcement: comparison of C57BL\/6J, 129X1\/SvJ, and 129S6\/SvEvTac inbred mice. Psychopharmacology 184(2):145\u2013154. \n                    https:\/\/doi.org\/10.1007\/s00213-005-0207-0","journal-title":"Psychopharmacology"},{"issue":"3","key":"4797_CR78","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/FBP.0b013e328345f8f2","volume":"22","author":"M Thomsen","year":"2011","unstructured":"Thomsen M, Caine SB (2011) False positive in the intravenous drug self-administration test in C57BL\/6J mice. Behav Pharmacol 22(3):239\u2013247. \n                    https:\/\/doi.org\/10.1097\/FBP.0b013e328345f8f2","journal-title":"Behav Pharmacol"},{"issue":"3","key":"4797_CR79","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1124\/jpet.109.162057","volume":"332","author":"M Thomsen","year":"2010","unstructured":"Thomsen M, Conn PJ, Lindsley C, Wess J, Boon JY, Fulton BS, Fink-Jensen A, Caine SB (2010a) Attenuation of cocaine\u2019s reinforcing and discriminative stimulus effects via muscarinic M1 acetylcholine receptor stimulation. J Pharmacol Exp Ther 332(3):959\u2013969. \n                    https:\/\/doi.org\/10.1124\/jpet.109.162057","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"4797_CR80","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00213-013-3256-9","volume":"231","author":"M Thomsen","year":"2014","unstructured":"Thomsen M, Fulton BS, Caine SB (2014) Acute and chronic effects of the M1\/M4-preferring muscarinic agonist xanomeline on cocaine vs. food choice in rats. Psychopharmacology 231(3):469\u2013479. \n                    https:\/\/doi.org\/10.1007\/s00213-013-3256-9","journal-title":"Psychopharmacology"},{"issue":"4","key":"4797_CR81","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1523\/JNEUROSCI.4037-08.2009","volume":"29","author":"M Thomsen","year":"2009","unstructured":"Thomsen M, Hall FS, Uhl GR, Caine SB (2009a) Dramatically decreased cocaine self-administration in dopamine but not serotonin transporter knock-out mice. J Neurosci 29(4):1087\u20131092. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.4037-08.2009","journal-title":"J Neurosci"},{"issue":"1","key":"4797_CR82","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1124\/jpet.109.156265","volume":"331","author":"M Thomsen","year":"2009","unstructured":"Thomsen M, Han DD, Gu HH, Caine SB (2009b) Lack of cocaine self-administration in mice expressing a cocaine-insensitive dopamine transporter. J Pharmacol Exp Ther 331(1):204\u2013211. \n                    https:\/\/doi.org\/10.1124\/jpet.109.156265","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"4797_CR83","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1007\/s00213-011-2516-9","volume":"220","author":"M Thomsen","year":"2012","unstructured":"Thomsen M, Lindsley CW, Conn PJ, Wessell JE, Fulton BS, Wess J, Caine SB (2012) Contribution of both M1 and M4 receptors to muscarinic agonist-mediated attenuation of the cocaine discriminative stimulus in mice. Psychopharmacology 220(4):673\u2013685. \n                    https:\/\/doi.org\/10.1007\/s00213-011-2516-9","journal-title":"Psychopharmacology"},{"issue":"3","key":"4797_CR84","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00213-009-1740-z","volume":"208","author":"M Thomsen","year":"2010","unstructured":"Thomsen M, Wess J, Fulton BS, Fink-Jensen A, Caine SB (2010b) Modulation of prepulse inhibition through both M1 and M4 muscarinic receptors in mice. Psychopharmacology 208(3):401\u2013416. \n                    https:\/\/doi.org\/10.1007\/s00213-009-1740-z","journal-title":"Psychopharmacology"},{"issue":"36","key":"4797_CR85","doi-asserted-by":"publisher","first-page":"8141","DOI":"10.1523\/JNEUROSCI.2077-05.2005","volume":"25","author":"M Thomsen","year":"2005","unstructured":"Thomsen M, Woldbye DP, Wortwein G, Fink-Jensen A, Wess J, Caine SB (2005) Reduced cocaine self-administration in muscarinic M5 acetylcholine receptor-deficient mice. J Neurosci 25(36):8141\u20138149. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.2077-05.2005","journal-title":"J Neurosci"},{"issue":"9","key":"4797_CR86","doi-asserted-by":"publisher","first-page":"3398","DOI":"10.1523\/JNEUROSCI.5620-09.2010","volume":"30","author":"S Threlfell","year":"2010","unstructured":"Threlfell S, Clements MA, Khodai T, Pienaar IS, Exley R, Wess J, Cragg SJ (2010) Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. J Neurosci 30(9):3398\u20133408. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.5620-09.2010","journal-title":"J Neurosci"},{"key":"4797_CR87","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3389\/fnsys.2011.00011","volume":"5","author":"S Threlfell","year":"2011","unstructured":"Threlfell S, Cragg SJ (2011) Dopamine signaling in dorsal versus ventral striatum: the dynamic role of cholinergic interneurons. Front Syst Neurosci 5:11. \n                    https:\/\/doi.org\/10.3389\/fnsys.2011.00011","journal-title":"Front Syst Neurosci"},{"issue":"31","key":"4797_CR88","doi-asserted-by":"publisher","first-page":"10526","DOI":"10.1523\/JNEUROSCI.2523-10.2010","volume":"30","author":"MM Torregrossa","year":"2010","unstructured":"Torregrossa MM, Sanchez H, Taylor JR (2010) d-cycloserine reduces the context specificity of pavlovian extinction of cocaine cues through actions in the nucleus accumbens. J Neurosci 30(31):10526\u201310533. \n                    https:\/\/doi.org\/10.1523\/JNEUROSCI.2523-10.2010","journal-title":"J Neurosci"},{"issue":"18","key":"4797_CR89","doi-asserted-by":"publisher","first-page":"7050","DOI":"10.1073\/pnas.87.18.7050","volume":"87","author":"DM Weiner","year":"1990","unstructured":"Weiner DM, Levey AI, Brann MR (1990) Expression of muscarinic acetylcholine and dopamine receptor mRNAs in rat basal ganglia. Proc Natl Acad Sci U S A 87(18):7050\u20137054. \n                    https:\/\/doi.org\/10.1073\/pnas.87.18.7050","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4797_CR90","doi-asserted-by":"publisher","unstructured":"Yamanaka K, Hori Y, Minamimoto T, Yamada H, Matsumoto N, Enomoto K, Aosaki T, Graybiel AM, Kimura M (2017) Roles of centromedian parafascicular nuclei of thalamus and cholinergic interneurons in the dorsal striatum in associative learning of environmental events. J Neural Transm (Vienna). \n                    https:\/\/doi.org\/10.1007\/s00702-017-1713-z","DOI":"10.1007\/s00702-017-1713-z"},{"issue":"4","key":"4797_CR91","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1016\/S0306-4522(01)00039-2","volume":"103","author":"Z Yan","year":"2001","unstructured":"Yan Z, Flores-Hernandez J, Surmeier DJ (2001) Coordinated expression of muscarinic receptor messenger RNAs in striatal medium spiny neurons. Neuroscience 103(4):1017\u20131024. \n                    https:\/\/doi.org\/10.1016\/S0306-4522(01)00039-2","journal-title":"Neuroscience"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-017-4797-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4797-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-017-4797-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T05:13:12Z","timestamp":1589605992000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-017-4797-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,18]]},"references-count":91,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["4797"],"URL":"https:\/\/doi.org\/10.1007\/s00213-017-4797-0","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,18]]},"assertion":[{"value":"18 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 November 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"C.W.L. is an inventor of multiple pending and issued patents that protect composition of matter for M<sub>1<\/sub> and M<sub>4<\/sub> ligands. All other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}